They used an immunohistochemical assay to detect the mutated protein p53, which is based on the fact that while wild-type p53 is present in healthy cells at low concentrations, mutant p53 proteins are often overexpressed and accumulated in the tumor cell nucleus [33,34]. Here, TP53 is linked to neoplasm.